|
× |
 |
Vortioxetine for Cognitive Impairment in Major Depressive Disorder During Post-COVID Syndrome: Real-World Evidence PDF |
$40.00 |
|
$40.00 |
|
× |
|
Pegylated Interferon and Ribavirin-Induced Depression in Chronic Hepatitis C: Role of Personality PDF |
$40.00 |
|
$40.00 |
|
× |
|
Repeated Ingestion of Grapefruit Juice Does Not Alter Clozapine's Steady-State Plasma Levels, Effectiveness, and Tolerability PDF |
$40.00 |
|
$40.00 |
|
× |
|
Prevalence of Psychiatric Comorbidities in Patients With Neurofibromatosis PDF |
$40.00 |
|
$40.00 |
|
× |
|
Psychiatric Comorbidity of Sex Offenses in a Military Forensic Sample PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Relationship Between Quality of Life and Clinical Efficacy From a Randomized Trial Comparing Olanzapine and Ziprasidone PDF |
$40.00 |
|
$40.00 |
|
× |
|
Duloxetine in the Prevention of Depressive Recurrences: A Randomized, Double-Blind, Placebo-Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Evaluation of Changes in Citalopram Prescribing Patterns Following a US Food and Drug Administration Alert: A Retrospective Cohort Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
Screening for DSM-5 Other Specified Feeding or Eating Disorder in a Weight-Loss Treatment-Seeking Obese Sample PDF |
$40.00 |
|
$40.00 |
|
× |
|
Disrupted Antioxidant Enzyme Activity and Elevated Lipid Peroxidation Products in Schizophrenic Patients With Tardive Dyskinesia PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Motivational Interviewing Group to Manage Cardiometabolic Risk on an Inpatient Psychiatry Unit PDF |
$40.00 |
|
$40.00 |
|
× |
|
COVID-19–Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine PDF |
$40.00 |
|
$40.00 |
|
× |
|
Antidepressant and Double Antidepressant Treatment for the Affective Disorder of Epilepsy PDF |
$40.00 |
|
$40.00 |
|
× |
|
Havana Syndrome: Social Contagion or Mass Psychogenic Illness? PDF |
$40.00 |
|
$40.00 |
|
× |
|
Zonisamide in the Treatment of Binge Eating Disorder With Obesity: A Randomized Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
|